NCT00517634View on ClinicalTrials.gov

Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Asthma

Interventions

DRUG

FP

Fluticasone Propionate 100 mcg BD

DRUG

SFC

Salmeterol/Fluticasone Propionate Combination 50/100 mcg BD

DRUG

Placebo

Matching Placebo

Trial Locations (2)

53792

GSK Investigational Site, Madison

M23 9QZ

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY